Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Products In Brief

This article was originally published in The Tan Sheet

Executive Summary

Vicks gets tough on mucus: Procter & Gamble extends its Vicks DayQuil line with two mucus-controlling liquids, the company announced Dec. 23. DayQuil Mucus Control helps loosen mucus for up to four hours, the Cincinnati company said, while DayQuil Mucus Control DM contains the cough suppressant dextromethorphan. Both products are sold in 6-ounce and 10-ounce bottles at suggested retail prices between $6.49 and $7.29. The stock-keeping units each contain 200 mg of guaifenesin, compared to 600 mg of the expectorant in Reckitt Benckiser's Mucinex
Advertisement

Related Content

Supplements Used For Autism Do Not Need Overt Claims To Draw Scrutiny
Supplements Used For Autism Do Not Need Overt Claims To Draw Scrutiny
Supplements Used For Autism Do Not Need Overt Claims To Draw Scrutiny

Topics

Advertisement
UsernamePublicRestriction

Register

PS103732

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel